Home › Funds › Two Sigma Investments › AVIR
Two Sigma Investments position in AVIR
ATEA PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)1.51M sh
Reported value held$7.01M
Portfolio Weight0.01%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 789.66K | $7.06M | New |
| Q1 2022 | 602.00K | $4.35M | Reduce |
| Q2 2022 | 110.52K | $785.00K | Reduce |
| Q3 2022 | 98.48K | $560.00K | Reduce |
| Q2 2023 | 175.18K | $655.17K | New |
| Q3 2023 | 54.10K | $162.29K | Reduce |
| Q4 2023 | 161.91K | $493.82K | Add |
| Q1 2024 | 372.25K | $1.50M | Add |
| Q2 2024 | 375.07K | $1.24M | Add |
| Q3 2024 | 341.76K | $1.14M | Reduce |
| Q4 2024 | 285.92K | $957.84K | Reduce |
| Q1 2025 | 251.75K | $752.73K | Reduce |
| Q1 2025 | 251.75K | $752.73K | Reduce |
| Q2 2025 | 366.61K | $1.32M | Add |
| Q2 2025 | 366.61K | $1.32M | Add |
| Q3 2025 | 471.29K | $1.37M | Add |
| Q4 2025 | 745.41K | $2.66M | Add |
| Q1 2026 | 1.86M | $10.03M | Add |
| Q2 2026 | 1.51M | $7.01M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AVIR
- Fidelity Management & Research (FMR) 12.00M sh · $55.82M · Q2 2026
- BlackRock Inc 8.72M sh · $40.55M · Q2 2026
- Vanguard Group 4.23M sh · $15.09M · Q4 2025
- Geode Capital Management 1.96M sh · $9.11M · Q2 2026
- Renaissance Technologies 1.13M sh · $5.26M · Q2 2026
- JPMorgan Chase & Co 945.92K sh · $4.36M · Q2 2026
- Northern Trust Corp 755.24K sh · $3.51M · Q2 2026
- Morgan Stanley 719.51K sh · $3.35M · Q2 2026
- Charles Schwab Investment Management 610.61K sh · $2.84M · Q2 2026
- Goldman Sachs Group 530.86K sh · $2.47M · Q2 2026
- D. E. Shaw & Co 345.19K sh · $1.61M · Q2 2026